<p>添加</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>作为您在 Google 上的首选新闻来源</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>立即添加</p>
<p>SciSparc Ltd. (SPRC) 周二宣布与 Xylo Technologies Ltd. 达成一项最终协议，收购一系列专利、商标和知识产权，涉及创新的内窥镜系统和医疗相机，包括 MUSE 系统。</p>
<p>公司将向 Xylo 发行一定数量的普通股，以作为收购资产的对价。</p>
<p>交易完成后，SciSparc 打算立即开始这些专利技术的商业化，预计将促进快速市场渗透和收入生成。</p>
<p>在盘前交易时，SPRC 上涨 21.3%，至 1.76 美元，纳斯达克上市。</p>
<p>如有意见和反馈，请联系：editorial@rttnews.com</p>
<p>商业新闻</p>

SPRC

<p>SciSparc Ltd. (SPRC) 宣布与 Xylo Technologies Ltd. 达成一项最终协议，收购内窥镜系统和医疗摄像头的专利及知识产权。该公司将以普通股作为资产的对价。在交易完成后，SciSparc 计划将这些技术商业化，以增强市场渗透率和收入。在盘前交易中，SPRC 股价上涨 21.3%，达到 1.76 美元，交易所为纳斯达克</p>

<p>Add</p>
<div class="lb-trans"><p>添加</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png" alt="" original-src="https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>as your preferred news source on Google</p>
<div class="lb-trans"><p>作为您在 Google 上的首选新闻来源</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png" alt="" original-src="https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>Add Now</p>
<div class="lb-trans"><p>立即添加</p>
</div><p>SciSparc Ltd. (SPRC), Tuesday announced a definitive agreement to acquire a treasury of patents, trademarks and intellectual property rights for innovative endoscopic systems and medical cameras, including the MUSE system, from Xylo Technologies Ltd.</p>
<div class="lb-trans"><p>SciSparc Ltd. (SPRC) 周二宣布与 Xylo Technologies Ltd. 达成一项最终协议，收购一系列专利、商标和知识产权，涉及创新的内窥镜系统和医疗相机，包括 MUSE 系统。</p>
</div><p>The company will issue an amount of its common shares to Xylo in consideration for the acquired assets.</p>
<div class="lb-trans"><p>公司将向 Xylo 发行一定数量的普通股，以作为收购资产的对价。</p>
</div><p>Upon closing of the deal, SciSparc intends to commence commercialization of these patented technologies immediately, which is expected to boost rapid market penetration and revenue generation.</p>
<div class="lb-trans"><p>交易完成后，SciSparc 打算立即开始这些专利技术的商业化，预计将促进快速市场渗透和收入生成。</p>
</div><p>In the pre-market hours, SPRC is moving up 21.3 percent, to $1.76 on the Nasdaq.</p>
<div class="lb-trans"><p>在盘前交易时，SPRC 上涨 21.3%，至 1.76 美元，纳斯达克上市。</p>
</div><p>For comments and feedback contact: editorial@rttnews.com</p>
<div class="lb-trans"><p>如有意见和反馈，请联系：editorial@rttnews.com</p>
</div><p>Business News</p>
<div class="lb-trans"><p>商业新闻</p>
</div>

SciSparc 将收购内窥镜系统和医用摄像机的知识产权